A second phase of this study will include biobank data from some 1,000 additional patients in Europe and the U.S, and it should be complete in the coming months, Diadem stated in the release. The test ...

There were also incidents when my mother spoke harshly to a stranger, and I gently told her that she needed to remember to be kind. She always accepted that information and reverted to her core ...

Evidence suggests that lithium can help treat and even prevent Alzheimer’s. Studies in an Alzheimer’s mouse model showed that treatment with AL001 prevented cognitive impairment, depression, and ...

“In the care home, I really wanted Jelly Drops to tackle dehydration and also to be really fun and engaging and sort of a social tool in the care home as well,” Hornby said in a video interview with ...

Rough start in trying for ‘more time’ Aducanumab’s path toward FDA review, and possible approval, has been rather unique and quite tumultuous. After early trial data indicated that aducanumab had an ...

The Phase 1b portion was a one-month ascending dose phase to assess its safety, tolerability, and pharmacological properties. In the Phase 2 efficacy portion, participants were randomly assigned ...

Alzheimer’s disease (AD) is associated with a gradual decline in memory and mental ability, due to the accumulation and spread of damage in the brain. It is an irreversible condition, with symptoms ...

No cure has yet been discovered to alleviate that financial burden, but early diagnosis could save as much as $7.9 trillion in total medical and long-term care costs for individuals in the U.S., ...

Mice with low levels of L-serine and D-serine had impaired spatial memory, which is the type of memory that allows us to remember where things are located, both on a short-term and long-term basis, as ...

The therapy, being developed jointly by Eisai and Biogen, is designed to slow Alzheimer’s progression. The FDA’s decision was based on clinical evidence from Study 201, a Phase 2b (NCT01767311) trial ...

Published in the April 2018 issue of the Journal of Alzheimer’s Disease , trial results showed improvement in memory and brain health for all who used the formula. Caregivers also reported that AD ...

Co-founder and managing art director Tavé Drake described Mirador as a “digital and print publication for the enjoyment of people experiencing brain change from Alzheimer’s, dementia-related ...